Spots Global Cancer Trial Database for pancreas
Every month we try and update this database with for pancreas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma | NCT01233375 | Metastatic Panc... | CO-1.01 | 18 Years - | Clovis Oncology, Inc. | |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer | NCT02900950 | Stage, Pancreat... Neoplasm, Resid... Pancreatic Neop... Periampullary C... | Multicolour ink... Monocolour inki... | 18 Years - 80 Years | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours | NCT05605522 | Pancreatic Duct... Squamous Cell C... Colorectal Canc... Gastric Cancer Ewing Sarcoma NTSR1 Expressin... Neuroendocrine ... | [225]-FPI-2059 [111In]-FPI-205... | 18 Years - | Fusion Pharmaceuticals Inc. | |
| LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy | NCT02985125 | Metastatic Panc... | LEE011 Everolimus | 18 Years - | Georgetown University | |
| Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | NCT01446952 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Florida Pancreas Collaborative Next Generation Biobank | NCT03851133 | Pancreatic Canc... Cancer Cachexia | Blood Sample Co... Tumor Sample co... Data Collection | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas | NCT00918853 | Pancreas Adenocarcinoma | resection of ad... | 18 Years - | Institut Paoli-Calmettes | |
| Project Survival-Prospective Biomarker Discovery | NCT02781012 | Pancreatic Neop... Pancreatic Canc... Pancreatitis Pancreatic Aden... Metastatic Panc... | 18 Years - | Pancreatic Cancer Research Team | ||
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | NCT01161186 | Pancreatic Neop... Pancreatic Canc... Adenocarcinoma | nab-paclitaxel,... | 18 Years - | University of California, San Francisco | |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
| Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas | NCT02822066 | Refractory Neop... | Electroporation | 18 Years - 100 Years | First Affiliated Hospital of Zhejiang University | |
| Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer | NCT02900950 | Stage, Pancreat... Neoplasm, Resid... Pancreatic Neop... Periampullary C... | Multicolour ink... Monocolour inki... | 18 Years - 80 Years | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT01318642 | Adenocarcinoma ... Locally Advance... Unresectable | Gemcitabine AMG 479 Placebo | 18 Years - | Amgen | |
| Understanding Genetic Incidental Findings in Your Family (UNIFY Study) | NCT02560896 | Familial Pancre... | 18 Years - | Mayo Clinic | ||
| CT Pancreas Perfusion | NCT00588367 | Pancreatic Duct... Chronic Pancrea... Autoimmune Panc... | Mayo Interactiv... | 18 Years - | Mayo Clinic | |
| Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer | NCT01298011 | Resectable Panc... | Gemcitabine and... | 18 Years - | Pancreatic Cancer Research Team | |
| Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma | NCT01474564 | Pancreatic Aden... | Blood draw | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | NCT01383538 | Pancreatic Canc... Adenocarcinoma Pancreatic Neop... | FOLFIRINOX, IPI... | 18 Years - | University of California, San Francisco | |
| MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer | NCT00769483 | Pancreatic Canc... Pancreatic Aden... | MK-0646 Gemcitabine Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | NCT01025570 | Pancreatic Canc... | Gemcitabine, Bo... | 18 Years - | University of California, San Francisco | |
| Shwachman Diamond Syndrome Registry and Study | NCT06056908 | Shwachman-Diamo... Shwachman-Diamo... | - | Boston Children's Hospital | ||
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma | NCT01660711 | Pancreatic Aden... | 5 Fluorouracil Leucovorin Irinotecan Oxaliplatin | 18 Years - | NorthShore University HealthSystem | |
| Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET) | NCT01169649 | PANCREAS Neuroendocrine | MK-2206 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer | NCT04087889 | Pancreatic Canc... | HB-adMSCs | - | Hope Biosciences | |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | NCT00966277 | Pancreatic Canc... Venous Thromboe... | Dalteparin | 18 Years - | M.D. Anderson Cancer Center | |
| Preoperative Stent Study | NCT00501176 | Pancreas Cancer | Plastic and met... | 20 Years - | Karolinska Institutet | |
| Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail | NCT00500968 | Pancreas Cancer Fistula | stent Distal pancreat... | 20 Years - | Karolinska Institutet | |
| Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | NCT00486460 | Pancreatic Canc... | Gemcitabine Curcumin Celebrex | 18 Years - | Tel-Aviv Sourasky Medical Center | |
| A Clinicobiological Database in Metastatic Digestive Cancers | NCT03978078 | Digestive Syste... | Biological coll... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Azacitidine and Pembrolizumab in Pancreatic Cancer | NCT03264404 | Pancreas Cancer | Pembrolizumab Azacitidine | 18 Years - | Columbia University | |
| Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma | NCT02863471 | Adenocarcinomas... | Gemcitabine | 18 Years - 100 Years | University Hospital Tuebingen | |
| Understanding Genetic Incidental Findings in Your Family (UNIFY Study) | NCT02560896 | Familial Pancre... | 18 Years - | Mayo Clinic | ||
| Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer | NCT00805688 | Pancreatic Canc... | Questionnaires Blood Draws Pedometer | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma | NCT00707278 | Cancer Pancreas | Radiation Thera... Capecitabine Oxaliplatin | 18 Years - | University of Utah | |
| A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane | NCT03003078 | Unresectable Lo... | OncoSil™ | 18 Years - | OncoSil Medical Limited | |
| Pediatric Longitudinal Cohort Study of Chronic Pancreatitis | NCT03672422 | Pancreatitis, C... Pancreatitis, A... | Blood sample Patient questio... Saliva sample Urine sample | 0 Years - 17 Years | University of Iowa | |
| A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer | NCT00401570 | Pancreatic Canc... | Volociximab Gemcitabine | 18 Years - | AbbVie | |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | NCT00402025 | Pancreatic Canc... | Talimogene Lahe... | 18 Years - | BioVex Limited | |
| Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection | NCT01058746 | Pancreatic Canc... | restrictive per... Liberal periope... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery | NCT00833859 | Pancreatic Neop... | GTX (gemcitabin... stereotactic bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer | NCT04119362 | Pancreatic Aden... | Quality of live... Optional transl... | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") | NCT01726582 | Pancreatic Aden... | Milestone 1: Ta... Milestone 2: Ch... Milestone 3: Ta... Milestone 3: Ch... Milestone 4: st... Milestone 4: Ch... Milestone 5: Ta... Milestone 5: Ch... Milestone 6: Ge... Milestone 6: Ch... Milestone 7: Ch... Milestone 8: Ta... Milestone 9: Ge... Milestone 10: N... | 18 Years - | Medical College of Wisconsin | |
| Pancreas Resection for Colorectal Metastasis: Retrospective Study | NCT05714475 | Pancreas Metast... Colorectal Canc... | Pancreas surger... | 18 Years - | Ospedale Generale Di Zona Moriggia-Pelascini | |
| Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy | NCT01931449 | Pancreatic Canc... Periampullary C... | Modified method... Routine digesti... | 18 Years - 80 Years | Southwest Hospital, China | |
| Phase I Trial of Combination of FOLFIRI and SOM 230 | NCT01434069 | Gastrointestina... | SOM230C LAR FOLFIRI Infusio... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer | NCT00336700 | Pancreatic Canc... | Gemcitabine Erlotinib | 18 Years - | University of Pittsburgh | |
| QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel | NCT02559674 | Advanced Pancre... | Gemcitabine Nab-paclitaxel ALT-803 | 18 Years - | Altor BioScience | |
| Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma | NCT02195180 | Pancreatic Aden... | ERY001 Gemcitabine 5-fluoro-uracil... | 18 Years - | ERYtech Pharma | |
| Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations | NCT05687188 | Pancreatic Canc... | Blood Sample Co... Tissue Sample C... Data Collection Medical Image C... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of Proton Therapy in Adjuvant Pancreatic Cancer | NCT03885284 | Resected Pancre... | mFOLFIRINOX Proton beam rad... | 18 Years - | Georgetown University | |
| Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas | NCT00689715 | Cystic Tumors o... | Endoscopic ultr... | 20 Years - 85 Years | Asan Medical Center | |
| Study of Pemetrexed for Second-Line Pancreas Cancer | NCT00864513 | Pancreas Cancer | pemetrexed | 18 Years - | Georgetown University | |
| Bethanechol Prior to Pancreatic Surgery | NCT03572283 | Pancreas Cancer | Bethanechol | 18 Years - | Columbia University | |
| Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer | NCT04627246 | Pancreatic Aden... | Autologous Dend... | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail | NCT00500968 | Pancreas Cancer Fistula | stent Distal pancreat... | 20 Years - | Karolinska Institutet | |
| A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer | NCT05630183 | Metastatic Panc... | Botensilimab Gemcitabine Nab-paclitaxel | 18 Years - | Agenus Inc. | |
| OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas | NCT01600807 | Pancreatic Canc... | Gemcitabine, Er... Gemcitabine, Er... | 18 Years - | Dana-Farber Cancer Institute | |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | NCT01383538 | Pancreatic Canc... Adenocarcinoma Pancreatic Neop... | FOLFIRINOX, IPI... | 18 Years - | University of California, San Francisco | |
| Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | NCT00183846 | Pancreatic Canc... Gastric Cancer Duodenum Cancer Bile Duct Cance... | irinotecan radiation thera... | 18 Years - | University of Southern California | |
| MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer | NCT00769483 | Pancreatic Canc... Pancreatic Aden... | MK-0646 Gemcitabine Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | NCT03697239 | Metastatic Panc... Pancreatic Canc... Pancreas Cancer Pancreatic Aden... Pancreatic Duct... Pancreatic Meta... | Ascorbic Acid Paclitaxel prot... Cisplatin Gemcitabine | 18 Years - | University of California, San Diego | |
| Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours | NCT00991601 | Tumors in Liver Tumors in Pancr... | FNAC (fine need... | 18 Years - | Herlev Hospital | |
| Study of Pemetrexed for Second-Line Pancreas Cancer | NCT00864513 | Pancreas Cancer | pemetrexed | 18 Years - | Georgetown University | |
| Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma | NCT01206296 | Pancreatic Aden... | Intraperitoneal... | 18 Years - | Medstar Health Research Institute | |
| Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | NCT00402025 | Pancreatic Canc... | Talimogene Lahe... | 18 Years - | BioVex Limited | |
| Molecularly Tailored Therapy for Pancreas Cancer | NCT01888978 | Pancreatic Canc... | Gem-OX Gem-5FU Gem-Tax Modified FOLFOX... Ox-Tax FOLFIRI Tax-Iri | 18 Years - | Georgetown University | |
| Side Population in Pancreatic Ductal Adenocarcinoma (PDAC) | NCT00936104 | Neoplasm Pancreas | 18 Years - 85 Years | University Hospital, Gasthuisberg | ||
| NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer | NCT06094140 | Pancreatic Canc... | Durvalumab Oxaliplatin Irinotecan Calcium folinat... Fluorouracil Pegylated G-CSF | 18 Years - | Australasian Gastro-Intestinal Trials Group | |
| Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | NCT00402025 | Pancreatic Canc... | Talimogene Lahe... | 18 Years - | BioVex Limited | |
| Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer | NCT01760694 | Pancreatic Canc... | Multi-Modality;... | 18 Years - | Southwestern Regional Medical Center | |
| Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer | NCT00047710 | Pancreatic Canc... | Bevacizumab Capecitabine Radiotherapy | - | M.D. Anderson Cancer Center | |
| Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | NCT00683358 | Pancreatic Canc... Pancreas Neopla... | VEGFR1-A24-1084... | 20 Years - 85 Years | Tokyo University | |
| DNA-mutation Analysis in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas | NCT03820531 | Pancreas Cyst | Next Generation... CEA and lipase Cytology Histology of re... | 18 Years - | Theresienkrankenhaus und St. Hedwig-Klinik GmbH | |
| Tight Glycemic Control by Artificial Pancreas | NCT00657995 | Pancreatic Neop... | Artificial Panc... | - | Kochi University | |
| Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer | NCT01080248 | Pancreatic Canc... | Gemcitabine Pazopanib | 18 Years - | Washington University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
